FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 22

Author

Admin 425 posts 0 comments

Articles

Managing Debt: Strategies That Actually Work

Admin Aug 14, 2025
Debt can feel overwhelming, whether it stems from credit cards, personal loans, mortgages, or unexpected…
Articles

Understanding Business Loans and Funding Options

Admin Aug 13, 2025
In today’s competitive market, securing the right financing is essential for starting, growing, or…
Featured News

Indian Districts Strengthen Finance Management to Improve Public Services

Admin Aug 11, 2025
Across India, district administrations are placing greater emphasis on robust financial management to…
Articles

Fintech Department and Taxation: Bridging Innovation and Compliance

Admin Aug 8, 2025
The rapid rise of financial technology (Fintech) has revolutionized how individuals, businesses, and…
Featured News

Fintech Startups Drive Financial Inclusion in Tier-2 and Tier-3 Cities

Admin Aug 7, 2025
Fintech innovation in India continues to disrupt traditional banking models as startups focus on expanding digital…
Whitepaper

Harnessing the Power of Conversational AI to Transform Customer Experience in…

Admin Aug 6, 2025
If there’s one thing that banking customers need the most, it’s their trust in the bank. After all, we’re talking…
Featured News

Provident Fund (PF) and Employee Awareness: The Missing Link

Admin Aug 5, 2025
While the Provident Fund (PF) remains one of the most beneficial financial tools for salaried employees in India,…
Articles

Smart Money Management for Middle-Class Families: Multiple Investment Plans That…

Admin Aug 4, 2025
Money management is essential for every income group, but for middle-class individuals and families, it plays…
Whitepaper

Mitigating Customer Attrition in Financial Institutions through Predictive…

Admin Aug 1, 2025
Predict, Prevent, and Reduce Customer Churn Using AI-Driven Insights In today’s competitive banking landscape,…
Banking

Internet Banking and Security: Building Trust in a Digital Economy

Admin Jul 31, 2025
Internet banking has revolutionized how consumers and businesses manage finances—offering convenience, speed, and…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • FinTech and Employee F&F Settlement: How Digital Financial Platforms Are Transforming the Employee Exit Process
    • How AI and Digital Innovation Are Transforming the Future of the FinTech Industry
    • The Power of Ecosystems for Banking
    • The Rise of Fintech: Transforming the Financial Landscape
    • Why Financial Services and Banks Need an Operational Data Layer

    ARTICLE

    Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint
    2026-08-13T11:36:00Z
    Clearmind Medicine has received Independent Data and Safety Monitoring Board (DSMB) approval to advance its clinical evaluation of CMND‑100 in patients with Alcohol Use Disorder (AUD) - a key milestone...


    Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives
    2026-08-13T11:30:00Z
    Agreement marks achievement of Cerenome’s full-year 2026 commercial payer coverage objective for CNSide


    MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
    2026-08-13T11:30:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering off-the-shelf allogeneic invariant natural killer T (iNKT) cell therapies for cancer and...


    Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
    2026-08-13T11:30:00Z
    Registrational RESET-Myositis® clinical data on track to be reported in mid-2027 to support 2H27 BLA submission for rese-cel


    Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
    2026-08-13T11:30:00Z
    - Q2 net ZEVASKYN® revenue increased 31% quarter-over-quarter to $11.4 million –


    Collegium Announces $50 Million Accelerated Share Repurchase Program
    2026-08-13T11:30:00Z
    STOUGHTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood...


    NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
    2026-08-13T11:30:00Z
    VANCOUVER, British Columbia, Aug. 13, 2026 (GLOBE NEWSWIRE) -- NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and...


    Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
    2026-08-13T11:30:00Z
    ‒ Q2 2026 Consolidated Revenue of $101.9 million ‒


    Ascendis Pharma Reports Second Quarter 2026 Financial Results
    2026-08-13T11:30:00Z
    – Q2 2026 product revenue of €315 million (+105% Y/Y), comprising €252 million for YORVIPATH®, €55 million for SKYTROFA®, and €8 million for YUVIWEL®


    MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA
    2026-08-13T11:30:00Z
    TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today...


    Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
    2026-08-13T11:15:00Z
    FULLERTON, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a biopharmaceutical company developing novel therapies for cancer and other serious diseases, today...


    Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
    2026-08-13T11:15:00Z
    Site Activation Initiated for Confirmatory Phase 3 Study of Iopofosine I 131 with New Drug Application Submission Planned for mid-2027 under the FDA’s Accelerated Approval Program


    Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
    2026-08-13T11:10:00Z
    Zelsuvmi® net product revenue grew 45% to $15.4 million during the second quarter of 2026 from $10.7 million in the first quarter of 2026


    ProQR Announces Second Quarter 2026 Operating and Financial Results
    2026-08-13T11:00:00Z
    LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) --  ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on...


    Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
    2026-08-13T11:00:00Z
    Advanced zolucatetide across multiple Wnt/β-catenin-driven diseases, including progress toward planned Phase 3 registrational trial in desmoid tumors


    Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
    2026-08-13T11:00:00Z
    • Initiated Study to Assess the Potential Impact of the Combination of Icovamenib and Low-Dose Semaglutide on Physical Function, Body Weight, Body Composition, Muscle Health, and Metabolic Outcomes


    Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients
    2026-08-13T11:00:00Z
    Phase 3 clinical trial of denifanstat in moderate to severe acne patients in the U.S. on track to initiate in second half of 2026


    Profusa Announces 1-for-4 Reverse Stock Split
    2026-08-13T11:00:00Z
    BERKELEY, California, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous...


    Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
    2026-08-13T11:00:00Z
    Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027


    Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-13T11:00:00Z
    NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a biotechnology company dedicated to immunotherapy research, today announced financial results for the...


    American Shared Hospital Services Reports Second Quarter and First Half 2026 Financial Results
    2026-08-13T11:00:00Z
    Second Quarter Revenue Increased 19% to $8.4 Million Driven by Strong Growth from Direct Patient Services


    6 Stress Points That Break Retail Customer Service During Peak Season
    2026-08-13T11:00:00Z
    Denver, CO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Retailers weighing how to scale customer service for peak season can now measure exactly where their operating model will come under pressure....


    LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
    2026-08-13T11:00:00Z
    10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026


    Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
    2026-08-13T11:00:00Z
    Updated data from the MICVO Phase 1 monotherapy study in 2L+ R/M HNSCC on track to be reported in Fall 2026; update to include detailed analyses of patients treated at...


    Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-13T11:00:00Z
    - Obexelimab BLA submission for the treatment of IgG4-RD accepted by FDA; PDUFA target action date of May 27, 2027 -


    MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-13T11:00:00Z
    EscharEx® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027


    Photys Therapeutics and Polymed Biopharmaceuticals Announce the Initiation of a Phase I Clinical Trial of PHT-776/HPB-143, an Oral IRAK4 PROTAC Degrader
    2026-08-13T11:00:00Z
    WALTHAM, Mass. and HANGZHOU, China, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Photys Therapeutics, Inc. (“Photys”), a proximity-based therapeutics company, and Polymed Biopharmaceuticals, Inc. (“Polymed”), a global biotech company focused on...


    Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer
    2026-08-13T11:00:00Z
    SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted...


    Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance
    2026-08-13T11:00:00Z
    ATLANTA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today...


    Montauk Brewing Company Announces New Collaboration with Morning Brew Inc.
    2026-08-13T11:00:00Z
    The Morning Brew, a Blonde Ale featuring Roasted Coffee Beans, is on tap now 

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.